The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has today recommended restricting the use of medicines containing ergot derivatives because of an increased risk ...
ERGOTAMINE tartrate (Gynergen) and the closely related dihydroergotamine methylsulfate (D.H.E. 45) appear to be the most successful pharmacologic agents yet proposed for the treatment of migraine ...
Ergot-derived dopamine receptor agonists, often used in the treatment of Parkinson's disease, have been associated with an increased risk of valvular heart disease. Clinically important regurgitation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results